[LHN]

Metformin for longevity: what TAME is trying to answer.

TAME is designed around whether one approved diabetes drug can affect multiple aging-related outcomes, but it is not a completed answer.

Published Jun 1, 2026Updated Jun 27, 2026Reviewed Jun 27, 20265 min read
LHN branded editorial cover for guide: Metformin for longevity: what TAME is trying to answer..

Simple answer

Metformin is approved for diabetes, not as a longevity treatment. TAME is important because it tries to test aging-related outcomes more directly.

At a glance

Evidence:Trial registeredRisk:Moderate riskStatus:Approved for another use

What the source says

  • Metformin has long clinical use for diabetes and metabolic disease contexts.
  • Geroscience interest focuses on whether it affects multiple age-related outcomes.
  • A trial design can clarify endpoints before public claims harden.

What it does not prove

  • It does not prove metformin is useful for every healthy person.
  • It does not prove biological age tests should guide use.
  • It does not make diabetes approval equivalent to longevity approval.

Practical takeaway

TAME is a question-asking effort, not a green light for self-directed longevity use.

Ask a qualified clinician if

you have diabetes, kidney concerns, medication interactions or are considering off-label longevity claims.

What to watch next

  • Trial funding, enrollment and endpoint updates.
  • Results by metabolic status and age group.
  • How outcomes compare with lifestyle and risk-factor management.

FAQs

Why does metformin matter to geroscience?

It is inexpensive, widely used and biologically plausible, making it a practical candidate for outcome-focused testing.

Is metformin a supplement?

No. It is a prescription medication with approved medical uses.

Source links

  • ClinicalTrials.gov - NIH / NLM

    Registry for trial status, endpoints and sponsors.

  • PubMed - NIH / NLM

    Primary literature search starting point.

Get the weekly longevity evidence briefing.

One plain-English email on the claims, studies and regulatory updates worth knowing - without protocols, hype or miracle claims.

No protocols. No miracle claims. No spam.

Choose your interests

Related reading